TrialOral oncology2021

Nanoparticle albumin-bound paclitaxel with cetuximab and carboplatin as first-line therapy for recurrent or metastatic head and neck cancer: A single-arm, multicenter, phase 2 trial.

Douglas Adkins et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.